메뉴 건너뛰기




Volumn 27, Issue 6, 2005, Pages 722-726

The pharmacokinetics and interactions of new antiepileptic drugs: An overview

Author keywords

Antiepileptic drugs; Interactions; Pharmacokinetics

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DILTIAZEM; DRUG METABOLITE; ETIRACETAM; FELBAMATE; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; GLYCOPROTEIN P; KETOCONAZOLE; LAMOTRIGINE; LICARZEPINE; MACROLIDE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; QUINIDINE; RIFAMPICIN; TIAGABINE; TOPIRAMATE; UNCLASSIFIED DRUG; VALPROIC ACID; VERAPAMIL; VIGABATRIN; ZONISAMIDE;

EID: 33646847032     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000179854.16846.67     Document Type: Conference Paper
Times cited : (45)

References (28)
  • 1
    • 4644301804 scopus 로고    scopus 로고
    • Progress report on new antiepileptic drugs: A summary of the Seventh Eilat conference on new antiepileptic drugs (EILAT VII)
    • Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the Seventh Eilat conference on new antiepileptic drugs (EILAT VII). Epilepsy Res. 2004;61:1-48.
    • (2004) Epilepsy Res , vol.61 , pp. 1-48
    • Bialer, M.1    Johannessen, S.I.2    Kupferberg, H.J.3
  • 2
    • 0034091545 scopus 로고    scopus 로고
    • The new antiepileptic drugs: Pharmacological and clinical aspects
    • Perucca E. The new antiepileptic drugs: pharmacological and clinical aspects. Curr Pharm Des. 2000;6:839-860.
    • (2000) Curr Pharm Des , vol.6 , pp. 839-860
    • Perucca, E.1
  • 3
    • 0029978025 scopus 로고    scopus 로고
    • The impact of new antiepileptic drugs on the prognosis of epilepsy: Seizure freedom should be the ultimate goal
    • Walker MC, Sander JWAS. The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal. Neurology. 1996;46:912-914.
    • (1996) Neurology , vol.46 , pp. 912-914
    • Walker, M.C.1    Sander, J.W.A.S.2
  • 4
    • 0038205341 scopus 로고    scopus 로고
    • General principles: Combination therapy and drug interactions
    • Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Philadelphia: Lippincott Williams & Wilkins, and other chapters therein on the various new AEDs
    • Perucca E, Levy RH. General principles: Combination therapy and drug interactions. In Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic Drugs, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2002, pp 96-102, and other chapters therein on the various new AEDs.
    • (2002) Antiepileptic Drugs, 5th Ed. , pp. 96-102
    • Perucca, E.1    Levy, R.H.2
  • 5
    • 0002482059 scopus 로고
    • General principles: Drug absorption, distribution and elimination
    • Levy RH, Mattson RH, Meldrum BS, eds. New York: Raven Press
    • Levy RH, Thummel KE, Unadkat JD. General principles: Drug absorption, distribution and elimination. In Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs, 4th ed. New York: Raven Press, 1995, pp 13-30.
    • (1995) Antiepileptic Drugs, 4th Ed. , pp. 13-30
    • Levy, R.H.1    Thummel, K.E.2    Unadkat, J.D.3
  • 8
    • 0012525623 scopus 로고    scopus 로고
    • Drugs as inducers of metabolic enzymes: Phenobarbital, phenytoin and carbamazepine
    • Levy RH, Thummel KE, Trager WF, Hansten PD, Eiehelbaum M, eds. Philadelphia: Lippincott, and other chapters therein
    • Abdel-Rhaman SM, Leeders JS. Drugs as inducers of metabolic enzymes: phenobarbital, phenytoin and carbamazepine. In Levy RH, Thummel KE, Trager WF, Hansten PD, Eiehelbaum M, eds. Metabolic Drug Interactions. Philadelphia: Lippincott, 2000, pp 673-690, and other chapters therein.
    • (2000) Metabolic Drug Interactions , pp. 673-690
    • Abdel-Rhaman, S.M.1    Leeders, J.S.2
  • 9
    • 0031800865 scopus 로고    scopus 로고
    • A mechanistic approach to drug interactions
    • Anderson GA. A mechanistic approach to drug interactions. Ann Pharmacother. 1998;32:554-563.
    • (1998) Ann Pharmacother , vol.32 , pp. 554-563
    • Anderson, G.A.1
  • 10
    • 0028787051 scopus 로고
    • Cytochrome P450 isozymes and antiepileptic drug interactions
    • Levy RH. Cytochrome P450 isozymes and antiepileptic drug interactions. Epilepsia. 1995;36(Suppl. 5):S8-S13.
    • (1995) Epilepsia , vol.36 , Issue.5 SUPPL.
    • Levy, R.H.1
  • 11
    • 0002936892 scopus 로고    scopus 로고
    • Prediction of drug interactions from in vitro studies: Basic principles - From in vitro to in vivo; an academic perspective
    • Levy RH, et al, eds. Philadelphia: Lippincott
    • Levy RH, Trager WF. Prediction of drug interactions from in vitro studies: Basic principles - from in vitro to in vivo; an academic perspective. In Levy RH, et al, eds. Metabolic Drug Interactions. Philadelphia: Lippincott, 2000, pp 21-28.
    • (2000) Metabolic Drug Interactions , pp. 21-28
    • Levy, R.H.1    Trager, W.F.2
  • 12
    • 0034042711 scopus 로고    scopus 로고
    • Induction of drug metabolizing enzymes: Pharmacokinetic and toxicological consequences in humans
    • Fuhr U. Induction of drug metabolizing enzymes: pharmacokinetic and toxicological consequences in humans. Clin Pharmacokinet. 2000;38:493-504.
    • (2000) Clin Pharmacokinet , vol.38 , pp. 493-504
    • Fuhr, U.1
  • 13
    • 0033972441 scopus 로고    scopus 로고
    • Pharmacokinetic - Pharmacodynamic consequences and clinical relevance of cytochrome 3A4 inhibition
    • Dresser GK, Spence JD, Bailey DG. Pharmacokinetic - pharmacodynamic consequences and clinical relevance of cytochrome 3A4 inhibition. Clin Pharmacokinet. 2000;38:41-57.
    • (2000) Clin Pharmacokinet , vol.38 , pp. 41-57
    • Dresser, G.K.1    Spence, J.D.2    Bailey, D.G.3
  • 14
    • 4644327804 scopus 로고    scopus 로고
    • Pharmacokinetic interactions of topiramate
    • Bialer M, Doose DR, Murthy B, et al. Pharmacokinetic interactions of topiramate. Clin Pharmacokinet. 2004;43:763-780.
    • (2004) Clin Pharmacokinet , vol.43 , pp. 763-780
    • Bialer, M.1    Doose, D.R.2    Murthy, B.3
  • 15
    • 20144373179 scopus 로고    scopus 로고
    • Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in presence and absence of enzyme induction by carbamazepine
    • Britzi M, Perucca E, Soback S, et al. Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in presence and absence of enzyme induction by carbamazepine. Epilepsia. 2005;46:378-384.
    • (2005) Epilepsia , vol.46 , pp. 378-384
    • Britzi, M.1    Perucca, E.2    Soback, S.3
  • 16
    • 21844447569 scopus 로고    scopus 로고
    • A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetic and metabolic profile of topiramate at steady-state in patients with epilepsy
    • in press
    • Mimrod D, Specchio LM, Britzi M, et al. A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetic and metabolic profile of topiramate at steady-state in patients with epilepsy. Epilepsia. 2005. (in press)
    • (2005) Epilepsia
    • Mimrod, D.1    Specchio, L.M.2    Britzi, M.3
  • 17
    • 0036218554 scopus 로고    scopus 로고
    • Changes in plasma protein binding have little clinical relevance
    • Benet LZ, Hoener B. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther. 2002;71:115-121.
    • (2002) Clin Pharmacol Ther , vol.71 , pp. 115-121
    • Benet, L.Z.1    Hoener, B.2
  • 18
    • 0036771085 scopus 로고    scopus 로고
    • Inhibition-based metabolic drug-drug interactions: Predictions from in vitro data
    • Yao C, Levy RH. Inhibition-based metabolic drug-drug interactions: predictions from in vitro data. J Pharm Sci. 2002;91:1923-1935.
    • (2002) J Pharm Sci , vol.91 , pp. 1923-1935
    • Yao, C.1    Levy, R.H.2
  • 19
    • 0036062267 scopus 로고    scopus 로고
    • Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women
    • Ragueneau-Majelessi I, Levy RH, Janik F. Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women. Epilepsia. 2002;43:697-702.
    • (2002) Epilepsia , vol.43 , pp. 697-702
    • Ragueneau-Majelessi, I.1    Levy, R.H.2    Janik, F.3
  • 20
    • 0037529325 scopus 로고    scopus 로고
    • Effect of topiramate or carbamazepine on the pharmacokinetics of oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and non-obese female subjects
    • Doose DR, Wang S-S, Padanabhan M, et al. Effect of topiramate or carbamazepine on the pharmacokinetics of oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and non-obese female subjects. Epilepsia. 2003;44:540-549.
    • (2003) Epilepsia , vol.44 , pp. 540-549
    • Doose, D.R.1    Wang, S.-S.2    Padanabhan, M.3
  • 21
    • 9444267085 scopus 로고    scopus 로고
    • Functional interaction of intestinal CYP3A4 and P-glycoprotein
    • Kivisto KT, Niemi M, Fromm MF. Functional interaction of intestinal CYP3A4 and P-glycoprotein. Fundam Clin Pharmacol. 2004;18:621-626.
    • (2004) Fundam Clin Pharmacol , vol.18 , pp. 621-626
    • Kivisto, K.T.1    Niemi, M.2    Fromm, M.F.3
  • 22
    • 2442719906 scopus 로고    scopus 로고
    • Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
    • Benet LZ, Cummins CL, Wu CY. Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. Int J Pharm. 2004;277:3-9.
    • (2004) Int J Pharm , vol.277 , pp. 3-9
    • Benet, L.Z.1    Cummins, C.L.2    Wu, C.Y.3
  • 23
    • 13244298981 scopus 로고    scopus 로고
    • Potential role of drug transporters in the pathogenesis of medically intractable epilepsy
    • Kwan P, Brodie MJ. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia. 2005;46:224-235.
    • (2005) Epilepsia , vol.46 , pp. 224-235
    • Kwan, P.1    Brodie, M.J.2
  • 24
    • 0035036730 scopus 로고    scopus 로고
    • Carbamazepine is not a substrate for P-glycoprotein
    • Owens A, Pirmohamed M, Tettey JN, et al. Carbamazepine is not a substrate for P-glycoprotein. Br Clin Pharamcol. 2001;51:345-349.
    • (2001) Br Clin Pharamcol , vol.51 , pp. 345-349
    • Owens, A.1    Pirmohamed, M.2    Tettey, J.N.3
  • 25
    • 0036816334 scopus 로고    scopus 로고
    • P-glycoprtein-mediated efflux of antiepileptic drugs: Preliminary studies in mdr1a knockout mice
    • Sills GJ, Kwan P, Butler E, et al. P-glycoprtein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice. Epilepsy Behav. 2002;3:427-432.
    • (2002) Epilepsy Behav , vol.3 , pp. 427-432
    • Sills, G.J.1    Kwan, P.2    Butler, E.3
  • 26
    • 0141519420 scopus 로고    scopus 로고
    • Interactions of antiepileptic drugs with human P-glycoprotein in vitro
    • Kerpen WJ, Lindenmaier H, Dormann SM, et al. Interactions of antiepileptic drugs with human P-glycoprotein in vitro. J Pharmacol Ther. 2003;307:262-267.
    • (2003) J Pharmacol Ther , vol.307 , pp. 262-267
    • Kerpen, W.J.1    Lindenmaier, H.2    Dormann, S.M.3
  • 27
    • 4544383423 scopus 로고    scopus 로고
    • Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans
    • Giessmann T, May K, Modess C, et al. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans. Clin Pharmacol Ther. 2004;76:192-200.
    • (2004) Clin Pharmacol Ther , vol.76 , pp. 192-200
    • Giessmann, T.1    May, K.2    Modess, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.